A Closer Look At SCFD1: Key Protein Involved in Intracellular Signaling and Cancer Therapy

Target Name: SCFD1

NCBI ID: G23256

SCFD1

A Closer Look At SCFD1: Key Protein Involved in Intracellular Signaling and Cancer Therapy

SCFD1 (Sec1 family domain containing 1) is a protein that is expressed in various cell types throughout the body. It is a key protein that is involved in the process of intracellular signaling, specifically in the regulation of cell signaling pathways. There is a growing interest in SCFD1 as a potential drug target or biomarker due to its unique structure and its involvement in several cellular processes.

The Sec1 family domain is a small protein domain that is located at the amino acid residue 1-20 of the protein. It is characterized by a unique Rossmann-fold that is composed of a combination of beta-helices and alpha-helices. This unique structure allows Sec1 to form a stable complex with other proteins, which is essential for its function.

SCFD1 is a 14-kDa protein that is expressed in a variety of tissues, including muscle, heart, brain, and pancreas. It is also highly expressed in cancer cells, which makes it an attractive target for cancer therapy.

One of the key functions of SCFD1 is its role in the regulation of cell signaling pathways. It is a key component of several signaling pathways that are involved in cell growth, differentiation, and survival. For example, SCFD1 is involved in the regulation of the Wnt signaling pathway, which is involved in the development and maintenance of tissues. It is also involved in the regulation of the TGF-beta signaling pathway, which is involved in cell growth and differentiation.

In addition to its role in signaling pathways, SCFD1 is also involved in the regulation of cellular processes that are important for cell survival. For example, it is involved in the regulation of cell apoptosis, which is the process by which cells die when they are no longer needed. This is important for maintaining tissue homeostasis and for ensuring that cells are not harmed by outside stimuli.

Another function of SCFD1 is its role in the regulation of cellular interactions. It is involved in the regulation of cell-cell interactions and in the formation of tight junctions, which are important for maintaining tissue structure and function.

As a potential drug target, SCFD1 is an attractive target because of its unique structure and its involvement in several cellular processes. Its role in the regulation of cell signaling pathways and its involvement in the regulation of cellular processes that are important for cell survival make it an attractive target for small molecule inhibitors. Additionally, its role in the regulation of cell-cell interactions make it a potential target for antibodies that can modulate cell-cell interactions.

In conclusion, SCFD1 is a protein that is expressed in various cell types throughout the body and is involved in the process of intracellular signaling. It is a key protein that is involved in the regulation of cell signaling pathways and its role in the regulation of cellular processes that are important for cell survival make it an attractive target for small molecule inhibitors and antibodies. Further research is needed to fully understand the unique functions of SCFD1 and its potential as a drug target or biomarker.

Protein Name: Sec1 Family Domain Containing 1

Functions: Plays a role in SNARE-pin assembly and Golgi-to-ER retrograde transport via its interaction with COG4. Involved in vesicular transport between the endoplasmic reticulum and the Golgi (By similarity)

The "SCFD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCFD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets